<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://www.plamedasia.com/why-plamed-asia</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-08-24</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618497927749-SXH79UDCU4LEBTQR73A3/icon-In-house+Feasibility+tool.png</image:loc>
      <image:title>Why Plamed Asia - In-house feasibility tool</image:title>
      <image:caption>We are supported by a fully established in-house business tool for reliable advice on feasibility at the bidding stage.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622040874551-X59Y508XD2BLUQXAK13J/icon-Guaranteed+Quality+and+Security.png</image:loc>
      <image:title>Why Plamed Asia - Guaranteed quality and security</image:title>
      <image:caption>As a part of the registration process, panel identities and detailed profiles including medical qualification and certification are requested and validated.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618498694765-3PQEO8NWF3LVWM975K3B/icon-Highly+skilled+moderator.png</image:loc>
      <image:title>Why Plamed Asia - Highly skilled moderators</image:title>
      <image:caption>Experience with pharma, ethnographic patient studies (emotional driver), and more; Preferred moderator requests allowed and those nominated by pharma clients.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1620049120621-ZAM8T1TDVCT2F7L7C9U5/icon-Compliance.png</image:loc>
      <image:title>Why Plamed Asia - Compliance</image:title>
      <image:caption>We ensure that your market research project is hassle-free and are completed successfully while following industry standards and compliance guidelines.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1621869603541-4VJACV2FK9HWXUIX1UVF/icon-Healthcare+Fieldwork+Experts.png</image:loc>
      <image:title>Why Plamed Asia - Healthcare fieldwork experts</image:title>
      <image:caption>Benefit from  our multi-lingual executives with extensive experience in healthcare. We know how to engage with healthcare professionals and different types of respondent to ensure high quality data. Listening is a great part of communication. We could help you to define which respondent to talk to and what method best fits the research objective for each market.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1616514664063-4F6U01BJZOIB3L147P9S/icon-One-stop+source+regional+support.png</image:loc>
      <image:title>Why Plamed Asia - One-stop source for regional support</image:title>
      <image:caption>Largest fieldwork team specialized in healthcare market research in Asia, covering 12 Asian countries.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618497296290-BWEUFG7S47G064MKKZLB/icon-Fast+%26+High+Quality+Data.png</image:loc>
      <image:title>Why Plamed Asia - Fast &amp; high quality data</image:title>
      <image:caption>Plamed Asia is the fieldwork business brand within the INTAGE Group. Headquartered in Japan, we are fully committed in high quality and understand that quality matters to clients. Our regional healthcare fieldwork specialists deliver Asia-wide fieldwork based on “Made in Japan” quality.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618647196797-ZR219PP8C9AO1R15IUPF/icon-panel.png</image:loc>
      <image:title>Why Plamed Asia - Proprietary HCP panel</image:title>
      <image:caption>Our proprietary HCP panel was developed locally in Asia for healthcare market research purposes only.  With detailed profiling, this well-managed and verified panel delivers fast and high quality response with cooperation rates as high as 25%.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1620172997578-RSDOBBPTJ02TBOIK18HG/icon-Great+sense+of+Ownership.png</image:loc>
      <image:title>Why Plamed Asia - Great sense of ownership</image:title>
      <image:caption>Dedicated fieldwork management to ensure co-ordination of processes, deliverables and progress reporting.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622645403234-H66NP508RPNU8MKTW5MU/shutterstock_1731325180-2.jpg</image:loc>
      <image:title>Why Plamed Asia</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/home</loc>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
    <lastmod>2025-02-21</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/ba3899e0-5795-4877-bca8-5c6e4013f0f7/logo-ephMRA-2.png</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1629811384558-HS1B6BYDCOLKNK74F7FN/Shaofei-v2.png</image:loc>
      <image:title>Home - Shaofei Deng</image:title>
      <image:caption>Associate Director</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622649142535-URVKA4U0DH23XX5MLCQ4/PMDA+Team+photo1.JPG</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1621670183175-53LIBE0TP1B6WT7P4EIL/interview+room+1_web+size_20160511_078.jpg</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1621670190517-Q4XDFLD6565VE1EZFS01/IMG_9335.JPG</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1621868359670-XIXIB69BM4QV6QJ1V6BM/web+size_20160511_082.jpg</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1620047663009-CFM7K3IJQHPOPXRB2QJY/web+size_20160511_065.jpg</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1620047655998-AH8J538A8C68YSU2E8BS/web+size_20160511_024.jpg</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1620047655500-V4RFGCSNT3BNGW73KAS7/web+size_20160511_035.jpg</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1620047662778-KYSYYXE2OA4W3EJ8QKX0/web+size_20160511_049.jpg</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1629811362723-ACWNFUEULCZW1DIX4MW3/Lisa-v2.png</image:loc>
      <image:title>Home - Lisa Tam</image:title>
      <image:caption>Director</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1616509584510-0UEQJIXGYNBM83UGPTZD/logo-Esomar21.png</image:loc>
      <image:title>Home - ESOMAR21</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1616509632209-MZ9L4057U419YYJ7KMAC/logo-Intellus.png</image:loc>
      <image:title>Home</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/e5143572-0114-48ff-af4b-684eb87d35d0/Shiori-profile-pic.png</image:loc>
      <image:title>Home - Shiori Chiba</image:title>
      <image:caption>Japan Office Manager</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1629810559836-2B8QDC3R0CC0V03RPS77/shutterstock_1616615986-min.jpg</image:loc>
      <image:title>Home</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/panel-details</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-03-14</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1615713775721-MOBQIVU115HUF0HT4UV6/shutterstock_95588296.jpg</image:loc>
      <image:title>Panel Details</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/coverage</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-08-24</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1621909248630-9QV9IVCGA1KUQNQWNOE0/map.png</image:loc>
      <image:title>Coverage</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622652439993-TE7XICCODF8GDDBT752Y/shutterstock_1756593041-2.jpg</image:loc>
      <image:title>Coverage - Our Reach</image:title>
      <image:caption>Access to millions of Healthcare Professionals &amp; panel members in Asia. Strong connection with hospital and office-based physicians, nurses, dentist, pharmacists, payers, C-levels &amp; many other stakeholders including:</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622645500878-7JLT11M0KFI4QRDWFVQT/shutterstock_326305964-2.jpg</image:loc>
      <image:title>Coverage</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/our-story-banner-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-07</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1616683328737-UHPC8QZKCVXWMM79G8D5/stock-photo-an-isolated-female-hand-holding-a-small-red-knitted-heart-at-the-grey-sky-background-with-icons-of-1286250832.jpeg</image:loc>
      <image:title>Our Story Banner</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/page-dp</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-17</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618583834513-9OJNYTZ16VAQJAYX3FUS/icon-DP.png</image:loc>
      <image:title>DP</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/case-study-qualitative</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-04-16</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/d40a5967-5585-4b45-b349-3045dbd01960/Multiple+Myeloma.jpg</image:loc>
      <image:title>Case Study - Qualitative - Current and Future Perspectives on Multiple Myeloma Treatment in Japan</image:title>
      <image:caption>This qualitative study focused on understanding current treatment approaches for multiple myeloma (MM) patients and identifying unmet needs. Additionally, it aimed to evaluate the potential profile of new products for MM. The study targeted a specific group of hematologists administering or well-versed in CAR-T therapy, one of the most advanced treatments for hematological cancers. The recruitment process spanned three weeks, followed by a five-day interview period with nine participants. Targeting this sample was challenging due to the specialized nature of CAR-T therapy. However, the study successfully demonstrated our capability to reach and engage with this niche group of healthcare professionals, providing valuable insights into the current landscape and prospects for MM treatment.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622646033657-D25NEZ1JVDPRR9ZY3L8N/shutterstock_267662933-2.jpg</image:loc>
      <image:title>Case Study - Qualitative - Insights into Treatment Approaches for CKD and Hypertension in Japan</image:title>
      <image:caption>This qualitative study aimed to understand the current treatment landscape for chronic diseases such as chronic kidney disease (CKD) and hypertension, and to gauge potential prescription behavior for new mechanisms of action (MOAs). The study involved 36 participants, including nephrologists, cardiologists, and internal medicine specialists. The recruitment process spanned three weeks, followed by a nine-day interview period. We conducted both in-person and online interviews, with three participants interviewed in person and 33 online. This flexibility highlighted our commitment to adapting to participants' preferences and circumstances. Despite the challenges of managing a large sample size and coordinating multiple interview formats, the study provided valuable insights into the current treatment situation for CKD and hypertension, as well as potential prescribing patterns for novel MOAs.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/529e127d-1820-4ee7-838e-18e1d772f50d/PsO+and+PsA.jpg</image:loc>
      <image:title>Case Study - Qualitative - Understanding Unmet Needs of PsO and PsA Patients in China and Japan</image:title>
      <image:caption>The three-phase study aimed to understand the unmet needs and challenges faced by PsO and PsA patients in China and Japan. The study involved a pulse survey, an online bulletin board, and follow-up qualitative interviews. Patients completed a 10-minute pulse survey before participating in a two-week online bulletin board discussion with the moderator and other patients. Following this, patients joined a 60-minute follow-up qualitative interview. We successfully recruited 30 patients in Japan and 40 patients in China, including those with only PsO or PsA and those with both conditions. Recruitment was completed within four weeks.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618644623713-IKXGZPCZRQD00NP18BS3/unsplash-image-WMSvsWzhM0g.jpg</image:loc>
      <image:title>Case Study - Qualitative - Advanced NSCLC patient journey study in China and Hong Kong</image:title>
      <image:caption>Client was aiming to conduct an study including qualitative IDIs online quantitative interviews. The method included 8 paired patient and caregiver interviews, 52 HCP interviews, 6 KOL interviews, and 2 pathology interviews in China. The sample size in Hong Kong was a bit smaller. We completed 3 paired patient and caregiver interviews, 26 HCP interviews and 2 payor interviews. The objective of the study was to understand the current market landscape and future opportunities for advanced NSCLC treatment. An in-home observation method was used to understand patient journey in-depth.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1616682005021-RNZMPAWPJXU3QMMTX50I/unsplash-image-5h_dMuX_7RE.jpg</image:loc>
      <image:title>Case Study - Qualitative - Orthopedic device market access study in China</image:title>
      <image:caption>The client was targeting n=23 heads of departments (HODs) from Top 50/100 Orthopedic hospitals in China for 60-minute qualitative TDIs. The sample included HODs from orthopedic, devices/equipment, finance, and procurement - as well as C-suite professionals. The objective of the study was to understand the economic value drivers for new orthopedic devices in China.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/015c85de-80bc-49fa-8964-f65255b33545/Ophthalmology.jpg</image:loc>
      <image:title>Case Study - Qualitative - Insights into Drug Pricing and Payers' Perspectives in Japanese Ophthalmology</image:title>
      <image:caption>The objective of this qualitative study was to gain insights into drug pricing policies and payers' perspectives on efficacy, specifically for ophthalmological diseases such as neovascular age-related macular degeneration (nAMD). The study targeted a rare and unique group of specialists. The recruitment process spanned three weeks, followed by a three-day interview period with three participants. This study illustrated the challenges of reaching such a niche target audience, as the payer’s component was the most demanding aspect due to Japan's unique insurance policies. Despite these hurdles, the study successfully engaged with these rare specialists, providing valuable insights into drug pricing and efficacy impressions from the payers' perspective within the ophthalmology therapeutic area.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618644575303-EDKMQWW4AV5TKCVSP2OV/unsplash-image-ruQ-_rc5tOo.jpg</image:loc>
      <image:title>Case Study - Qualitative - Vaccines study across APAC</image:title>
      <image:caption>The client was aiming to conduct a large-scale qualitative study (n=30s per country) concerning market entry assessment across APAC countries (China, Japan, Korea, Taiwan, Australia) for vaccines targeting two infectious disease areas. The objective of the study was to speak with various stakeholders, such as current and ex-payors, HCPs, patients and KOLs about the need for / value of a vaccine.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1623476194873-2FUS95BAUOWTKTTT0FH3/shutterstock_1295341387-2.jpg</image:loc>
      <image:title>Case Study - Qualitative</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/contact-us</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-16</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622646900314-WKF1E3AZRYXPFWZAHF9F/shutterstock_1270631311-2.jpg</image:loc>
      <image:title>Contact Us</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/qualitative</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-17</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618583485931-U9XJAJD9N256637IUTF2/icon-Qualitative-v3.png</image:loc>
      <image:title>Qualitative</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/translation</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-17</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618646252139-JLP2ALCKY89I9T4WJXJN/icon-translation.png</image:loc>
      <image:title>Translation</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618646347196-SS8WU2U1208YPULEXLLE/Jpn+facility+1.jpg</image:loc>
      <image:title>Translation - Title</image:title>
      <image:caption>Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/news</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-06-02</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622646647371-DK5DX6GEKCFERD74T2EL/shutterstock_1492797776-2.jpg</image:loc>
      <image:title>News</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622646695990-VY1IDFDCPVEB0JL5QBMU/shutterstock_524089942-2.jpg</image:loc>
      <image:title>News</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622646759580-IFYELZ3UL8RNIMTPOR83/shutterstock_403209727-2.jpg</image:loc>
      <image:title>News</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/outcome-research</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-17</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618583786875-QQ7GELQYKWQDBW76Q1PB/icon-Outcome-Research.png</image:loc>
      <image:title>Outcome Research</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/privacy-policy</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-08-24</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1615713781278-11EK68V638PU85ZYEYFM/image-asset.jpeg</image:loc>
      <image:title>Privacy Policy</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/quantitative</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-05-03</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618584043250-AQNOCVATS89D7QW5LSG0/icon-QUANTITATIVE-v3.png</image:loc>
      <image:title>Quantitative</image:title>
      <image:caption>Quantitative</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618583485931-U9XJAJD9N256637IUTF2/icon-Qualitative-v3.png</image:loc>
      <image:title>Quantitative</image:title>
      <image:caption>Qualitative</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618584043250-AQNOCVATS89D7QW5LSG0/icon-QUANTITATIVE-v3.png</image:loc>
      <image:title>Quantitative</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618583786875-QQ7GELQYKWQDBW76Q1PB/icon-Outcome-Research.png</image:loc>
      <image:title>Quantitative</image:title>
      <image:caption>Outcome Research</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618583834513-9OJNYTZ16VAQJAYX3FUS/icon-DP.png</image:loc>
      <image:title>Quantitative</image:title>
      <image:caption>DP</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/key-contact</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-02-21</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1629811384558-HS1B6BYDCOLKNK74F7FN/Shaofei-v2.png</image:loc>
      <image:title>Key Contact - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1629811362723-ACWNFUEULCZW1DIX4MW3/Lisa-v2.png</image:loc>
      <image:title>Key Contact - Lisa Tam</image:title>
      <image:caption>Director Lisa started her career in market research in 1995, working exclusively in healthcare data collection in the APAC region. From learning the fundamentals for fieldwork (e.g. recruitment and moderation) in the early years to building a healthcare panel in Asia and managing multiple offices with different cultures, her passion for delivering valued-added research to clients; and ultimately helping the patients, has never faltered. Her current role involves resource development and providing strategy leadership and long-term vision to effectively growing the capabilities of the organization while ensuring overall operating efficiency and profitability. Lisa speaks native Cantonese, fluent English and Mandarin. “Market research has taken me all over the world. It is vital to think globally, deliver and respect local wisdom and influence the world in a positive way. That is my lifetime mission.”</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/e5143572-0114-48ff-af4b-684eb87d35d0/Shiori-profile-pic.png</image:loc>
      <image:title>Key Contact - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/methods</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-06-21</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622645791448-HRHMVHDCAI1M8FWNE23L/shutterstock_1781039678-2.jpg</image:loc>
      <image:title>Methods</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/case-study-quantitative-old</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-02-27</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1629810634877-SIR6E64YXBZUUJO07RY5/shutterstock_388629514.jpg</image:loc>
      <image:title>Case Study - Quantitative - Patient record form study in Hong Kong</image:title>
      <image:caption>The client was aiming to collect patient record forms for various type of patients in Hong Kong, including diabetes patients, HER2 breast cancer patients, etc. Each patient form took about 5-10 minutes to complete and we managed to collect over 200 PRFs for each therapy area (TA).</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622646555459-0VQ1AOLQRXZ3TYNLJ8IB/shutterstock_1680298327-2.jpg</image:loc>
      <image:title>Case Study - Quantitative - Impact of COVID study in APAC</image:title>
      <image:caption>Our client was aiming to conduct a quick online study across several TAs to understand the impact of COVID to their daily practices in China and Japan. We targeted physicians treating prostate cancer, PAH, multiple myloema, IBD, and psoriasis. We successfully closed the study based on the quotas set (n=260s for each country for a 15-minute survey). The study was completed in just 7-10 days for both countries.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622646192627-UM21FVO1DGYFHAJLN99B/shutterstock_1469010173-2.jpg</image:loc>
      <image:title>Case Study - Quantitative - Hemophilia B patient chart study in Japan</image:title>
      <image:caption>Our client was aiming to collecting a challenging number of hemophilia B patient charts in Japan as part of an online quantitative study. We successfully collected date from a total of 35 hematologists + pediatricians with a total of 126 patient records completed... resulting in a very happy and satisfied client.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622646279536-3ET23SZ0IGFB2SM9L93L/shutterstock_1674567586-2.jpg</image:loc>
      <image:title>Case Study - Quantitative - Advanced GIST (recurrent, metastatic and/or non-resectable) study in Japan</image:title>
      <image:caption>It has been reported that GIST is such a rare cancer that affects only 1 in 100,000 people, and there are only 500-1,000 metastatic and/or non-resectable GIST patients newly diagnosed per year. Despite this challenge we conducted a quantitative study among physicians who treat advanced GIST patients. We outperformed our own target and achieved 80 completes within just 2 weeks… which led to satisfied client.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1629810666062-10I49BHYAD4PBOPHQYI5/shutterstock_295279178.jpg</image:loc>
      <image:title>Case Study - Quantitative - Hospital capital expenditure study for Japan</image:title>
      <image:caption>Our client was aiming to conduct an online quantitative among decision makers and influences at hospitals throughout Japan. We targeted hospital directors, deputy directors, finance/procurement representative, head of departments (HODs), and head nurses. We collected responses for a 10-minute survey from 100+ decision makers and influences from 100+ unique hospitals with 100 or more beds throughout Japan.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1623769131904-17DY5OBB9SNJIZW7NFH7/shutterstock_1295341387-2.jpg</image:loc>
      <image:title>Case Study - Quantitative</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/new-page-1</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-06-06</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622645500878-7JLT11M0KFI4QRDWFVQT/shutterstock_326305964-2.jpg</image:loc>
      <image:title>New Page</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/rsvp-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-08-24</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495042904198-FP1JXF34U7GGDPQWXAN1/img_0843.jpg</image:loc>
      <image:title>RSVP</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/he-proposed-banner-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-08-24</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495034837318-RSWH43UNFJDRIBG2YSPU/img_0730.jpg</image:loc>
      <image:title>He Proposed Banner</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/our-story-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-08-24</lastmod>
  </url>
  <url>
    <loc>https://www.plamedasia.com/case-study-qualitative-copy</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-02-27</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/116d8dd0-161d-417a-b372-c6826cff8ba1/Tracking+Study+with+PRFs+in+Hong+Kong.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy) - Tracking Study with PRFs in Hong Kong</image:title>
      <image:caption>We conducted a two-wave market tracking study focusing on various disease treatments, including Type 2 Diabetes Management, Heart Failure, and Chronic Kidney Disease in Hong Kong. The objective was to understand brand awareness and usage performance of various brands in these therapy areas. The survey, lasting 60 minutes, included the main survey and five patient record forms. In each wave, we collected responses from 47 doctors working in public hospitals (including endocrinologists, cardiologists, nephrologists, GOPC, and family medicine) and 21 doctors working in private hospitals (endocrinologists, cardiologists, nephrologists). All doctors were recruited from a target list. Fieldwork for each wave was completed within six weeks.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1616682005021-RNZMPAWPJXU3QMMTX50I/unsplash-image-5h_dMuX_7RE.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy) - Orthopedic device market access study in China</image:title>
      <image:caption>The client was targeting n=23 heads of departments (HODs) from Top 50/100 Orthopedic hospitals in China for 60-minute qualitative TDIs. The sample included HODs from orthopedic, devices/equipment, finance, and procurement - as well as C-suite professionals. The objective of the study was to understand the economic value drivers for new orthopedic devices in China.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618644623713-IKXGZPCZRQD00NP18BS3/unsplash-image-WMSvsWzhM0g.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy) - Advanced NSCLC patient journey study in China and Hong Kong</image:title>
      <image:caption>Client was aiming to conduct an study including qualitative IDIs online quantitative interviews. The method included 8 paired patient and caregiver interviews, 52 HCP interviews, 6 KOL interviews, and 2 pathology interviews in China. The sample size in Hong Kong was a bit smaller. We completed 3 paired patient and caregiver interviews, 26 HCP interviews and 2 payor interviews. The objective of the study was to understand the current market landscape and future opportunities for advanced NSCLC treatment. An in-home observation method was used to understand patient journey in-depth.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1618644575303-EDKMQWW4AV5TKCVSP2OV/unsplash-image-ruQ-_rc5tOo.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy) - Vaccines study across APAC</image:title>
      <image:caption>The client was aiming to conduct a large-scale qualitative study (n=30s per country) concerning market entry assessment across APAC countries (China, Japan, Korea, Taiwan, Australia) for vaccines targeting two infectious disease areas. The objective of the study was to speak with various stakeholders, such as current and ex-payors, HCPs, patients and KOLs about the need for / value of a vaccine.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1620051841894-999GTS7J1WUIEOQCUY3L/unsplash-image-IocJwyqRv3M.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy) - Insights into Treatment Approaches for CKD and Hypertension in Japan</image:title>
      <image:caption>This qualitative study aimed to understand the current treatment landscape for chronic diseases such as chronic kidney disease (CKD) and hypertension, and to gauge potential prescription behavior for new mechanisms of action (MOAs). The study involved 36 participants, including nephrologists, cardiologists, and internal medicine specialists. The recruitment process spanned three weeks, followed by a nine-day interview period. We conducted both in-person and online interviews, with three participants interviewed in person and 33 online. This flexibility highlighted our commitment to adapting to participants' preferences and circumstances. Despite the challenges of managing a large sample size and coordinating multiple interview formats, the study provided valuable insights into the current treatment situation for CKD and hypertension, as well as potential prescribing patterns for novel MOAs.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1622646033657-D25NEZ1JVDPRR9ZY3L8N/shutterstock_267662933-2.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy) - Insights into Treatment Approaches for CKD and Hypertension in Japan</image:title>
      <image:caption>This qualitative study aimed to understand the current treatment landscape for chronic diseases such as chronic kidney disease (CKD) and hypertension, and to gauge potential prescription behavior for new mechanisms of action (MOAs). The study involved 36 participants, including nephrologists, cardiologists, and internal medicine specialists. The recruitment process spanned three weeks, followed by a nine-day interview period. We conducted both in-person and online interviews, with three participants interviewed in person and 33 online. This flexibility highlighted our commitment to adapting to participants' preferences and circumstances. Despite the challenges of managing a large sample size and coordinating multiple interview formats, the study provided valuable insights into the current treatment situation for CKD and hypertension, as well as potential prescribing patterns for novel MOAs.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/529e127d-1820-4ee7-838e-18e1d772f50d/PsO+and+PsA.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy) - Understanding Unmet Needs of PsO and PsA Patients in China and Japan</image:title>
      <image:caption>The three-phase study aimed to understand the unmet needs and challenges faced by PsO and PsA patients in China and Japan. The study involved a pulse survey, an online bulletin board, and follow-up qualitative interviews. Patients completed a 10-minute pulse survey before participating in a two-week online bulletin board discussion with the moderator and other patients. Following this, patients joined a 60-minute follow-up qualitative interview. We successfully recruited 30 patients in Japan and 40 patients in China, including those with only PsO or PsA and those with both conditions. Recruitment was completed within four weeks.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/015c85de-80bc-49fa-8964-f65255b33545/Ophthalmology.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy) - Insights into Drug Pricing and Payers' Perspectives in Japanese Ophthalmology</image:title>
      <image:caption>The objective of this qualitative study was to gain insights into drug pricing policies and payers' perspectives on efficacy, specifically for ophthalmological diseases such as neovascular age-related macular degeneration (nAMD). The study targeted a rare and unique group of specialists. The recruitment process spanned three weeks, followed by a three-day interview period with three participants. This study illustrated the challenges of reaching such a niche target audience, as the payer’s component was the most demanding aspect due to Japan's unique insurance policies. Despite these hurdles, the study successfully engaged with these rare specialists, providing valuable insights into drug pricing and efficacy impressions from the payers' perspective within the ophthalmology therapeutic area.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/d40a5967-5585-4b45-b349-3045dbd01960/Multiple+Myeloma.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy) - Current and Future Perspectives on Multiple Myeloma Treatment in Japan</image:title>
      <image:caption>This qualitative study focused on understanding current treatment approaches for multiple myeloma (MM) patients and identifying unmet needs. Additionally, it aimed to evaluate the potential profile of new products for MM. The study targeted a specific group of hematologists administering or well-versed in CAR-T therapy, one of the most advanced treatments for hematological cancers. The recruitment process spanned three weeks, followed by a five-day interview period with nine participants. Targeting this sample was challenging due to the specialized nature of CAR-T therapy. However, the study successfully demonstrated our capability to reach and engage with this niche group of healthcare professionals, providing valuable insights into the current landscape and prospects for MM treatment.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/604dd5eb6622412b2d854247/1623476194873-2FUS95BAUOWTKTTT0FH3/shutterstock_1295341387-2.jpg</image:loc>
      <image:title>Case Study - Qualitative (Copy)</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/he-proposed-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-12</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044559791-DN2GA1TPSU4MM9DCYRI8/img_0190.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044605038-IGCCB723IGI7WN0UK1GV/img_0163.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044642527-MAY0V9WZ4W7X0FV3BU2U/img_0231.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044871078-8NI3O5I3P9KWWQHPNH0E/img_0258.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044908196-IIJJ5QS9MBDZFZ9K8SHP/img_0266.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044959029-P8ZEA4L0HJTRYC2EU1IW/img_0330.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044671398-4SUWW48ERRUJ5GKQK46P/img_0346.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044693820-VU9WEZ8MVDA0A6NTKKB1/img_0358.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044436124-7R1XOKXRUUKQHB21F23U/img_0373.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495043222264-CCEQEWAALEISGNMTLF7P/img_0436-darkened.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044717273-GG7Z4FLM0T4YMTTTF3DD/img_0473.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044750718-IKWCUHCTDVWKI6RT5GOO/img_0464.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044537882-YBOREDULIPCA7PIVKJJ0/img_0512.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044457805-EQH7HNPBNVVWWHB4ISSX/img_0517.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495043192376-UGDYITL76XCTB2RGVLMW/img_0531.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495043215186-J843CTF1WXF7HHBQAPT6/img_0563.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495045200053-31FOPTI3QGHB4X6MV0H9/img_0618-edit+%281%29.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495043194035-ULT3T6RVJW4FAUEMFAME/img_0629.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495043211464-56KZYE1E09GPOF4IJCEQ/img_0611.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495044489949-GFYDAT80UJUJB0BF73YL/img_0964.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495043236147-GBI6N3MHBK43XY8NEFYO/img_0730.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495045251428-FGP4VE3ONTIB8S4OBYMX/img_0764.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495043240134-VOO6GZ8B07KG7XFK21R7/img_0823.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495043245084-UM7Q6DVANTLQIYXVPG1K/img_0843.jpg</image:loc>
      <image:title>He Proposed</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/may-23rd-2017-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-12</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495042238758-L5VGUTCN97QJFR7GUY65/img_0618-edit.jpg</image:loc>
      <image:title>May 23rd, 2017</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/she-said-yes-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-12</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495035723747-FQF4BQ31LJUA674MOP8S/img_0823.jpg</image:loc>
      <image:title>She Said Yes</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/accommodations-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-12</lastmod>
  </url>
  <url>
    <loc>https://www.plamedasia.com/portland-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-12</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495042286352-DNHYZW98J24LA6J2ENI2/img_0563.jpg</image:loc>
      <image:title>Portland</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/ceremony-and-reception-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-12</lastmod>
  </url>
  <url>
    <loc>https://www.plamedasia.com/best-friends-banner-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-12</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495033848916-IN0JO37YDV6LJ6SYE9TU/img_0436-darkened.jpg</image:loc>
      <image:title>Best Friends Banner</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/stay-warm-banner-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-12</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495042504164-CUI68EGRBAQAKCQBX4XT/img_0611.jpg</image:loc>
      <image:title>Stay Warm Banner</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.plamedasia.com/stoked-sonny</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-05-12</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/591c5d2ae4fcb596503cdc21/1495042763231-S19GHWG5MOVALQ9J67L4/img_0629.jpg</image:loc>
      <image:title>Stoked Banner</image:title>
    </image:image>
  </url>
</urlset>

